{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:42:38Z","timestamp":1792172558100,"version":"4.4.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015613","name":"Lille University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.autrev.2024.103536","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T14:06:23Z","timestamp":1711634783000},"page":"103536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prevalence of anti-Ro52-kDa\/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis"],"prefix":"10.1016","volume":"23","author":[{"given":"Marie-Elise","family":"Martel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Leurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Behal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Chepy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Collet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Sanges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Dubucquoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Dauchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Sobanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2024.103536_bb0005","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.autrev.2024.103536_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.930970","article-title":"Can antinuclear antibodies have a pathogenic role in systemic sclerosis?","volume":"13","author":"Chepy","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103536_bb0015","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2665-9913(20)30010-2","article-title":"The future of treatment in systemic sclerosis: can we design better trials?","volume":"2","author":"Pope","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.autrev.2024.103536_bb0020","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/S2665-9913(19)30144-4","article-title":"The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements","volume":"2","author":"Hoffmann-Vold","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.autrev.2024.103536_bb0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/08916934.2012.732131","article-title":"Clinical associations of anti-SSA\/Ro60 and anti-Ro52\/TRIM21 antibodies: diagnostic utility of their separate detection","volume":"46","author":"Men\u00e9ndez","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2024.103536_bb0030","first-page":"722","article-title":"Immunoserological aspects of idiopathic inflammatory muscle disease","volume":"112","author":"Rozman","year":"2000","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.autrev.2024.103536_bb0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2249.1997.4081308.x","article-title":"Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy","volume":"109","author":"Rutjes","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2024.103536_bb0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103536_bb0045","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","article-title":"Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes","volume":"9","author":"Koenig","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103536_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009599","article-title":"60 kD Ro and nRNP a frequently initiate human lupus autoimmunity","volume":"5","author":"Heinlen","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2024.103536_bb0055","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1002\/art.39316","article-title":"Interpretation of an extended autoantibody profile in a well-characterized Australian systemic sclerosis (scleroderma) cohort using principal components analysis","volume":"67","author":"Patterson","year":"2015","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.autrev.2024.103536_bb0060","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","article-title":"Latest update on the Ro\/SS-A autoantibody system","volume":"8","author":"Schulte-Pelkum","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103536_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103013","article-title":"An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management","volume":"21","author":"Decker","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103536_bb0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2012.02.013","article-title":"Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis","volume":"12","author":"Op De Be\u00e9ck","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103536_bb0075","first-page":"1217","article-title":"AB0033 B regulatory cells positively correlate with antibodies against ss-a ro52 in systemic sclerosis","volume":"77","author":"Mavropoulos","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103536_bb0080","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/08916934.2017.1357699","article-title":"Disease-related autoantibody profile in patients with systemic sclerosis","volume":"50","author":"Liaskos","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2024.103536_bb0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3906\/sag-1708-67","article-title":"An analysis of the relationship between autoantibodies and clinical findings in patients with systemic sclerosis","volume":"48","author":"Yayla","year":"2018","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.autrev.2024.103536_bb0090","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar3763","article-title":"Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis","volume":"14","author":"Hudson","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103536_bb0095","doi-asserted-by":"crossref","first-page":"R172","DOI":"10.1186\/ar3495","article-title":"Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features","volume":"13","author":"Mierau","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103536_bb0100","first-page":"1509","article-title":"AB0743 The clinical manifestations in anti-ro52 antibody- positive patients with systemic sclerosis; a retrospective case control study","volume":"77","author":"Kawata","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103536_bb0105","first-page":"33","article-title":"Serological and clinical profile of systemic sclerosis: analysis in a cohort of patients from a single center in northern Italy","volume":"153","author":"Priora","year":"2018","journal-title":"G Ital Dermatol E Venereol Organo Uff Soc Ital Dermatol E Sifilogr"},{"key":"10.1016\/j.autrev.2024.103536_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cca.2019.01.020","article-title":"Evaluation of a commercial immunoassay for autoantibodies in Chinese Han systemic sclerosis population","volume":"491","author":"Liu","year":"2019","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"10.1016\/j.autrev.2024.103536_bb0115","first-page":"S131","article-title":"Monospecific anti-Ro52\/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival","volume":"33","author":"Wodkowski","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2024.103536_bb0120","first-page":"402","article-title":"FRI0260 Survival, causes of death and mortality risk factors in systemic sclerosis","volume":"71","author":"Ovalles-Bonilla","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103536_bb0125","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103536_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2020.06.021","article-title":"Extended myositis-specific and -associated antibodies profile in systemic sclerosis: a cross-sectional study","volume":"88","author":"Leurs","year":"2021","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2024.103536_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.autrev.2024.103536_bb0140","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2024.103536_bb0145","series-title":"FRI0414 Evaluation of a novel multi-analyte assay for the detection of autoantibodies in the diagnosis of systemic sclerosis","volume":"vol. 77","author":"Meroni","year":"2018"},{"key":"10.1016\/j.autrev.2024.103536_bb0150","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/1756-185X.13060","article-title":"Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais","volume":"20","author":"Foocharoen","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103536_bb0155","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s10067-015-2981-3","article-title":"A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort","volume":"34","author":"Chang","year":"2015","journal-title":"New Zealand Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103536_bb0160","article-title":"Anti-SSA\/Ro52 autoantibodies in scleroderma: results of an observational, cross-sectional study","volume":"32","author":"S\u00e1nchez-Montalv\u00e1","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2024.103536_bb0165","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/1756-185X.12322","article-title":"Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort","volume":"18","author":"Sujau","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103536_bb0170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2012.07.005","article-title":"Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis","volume":"12","author":"Villalta","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103536_bb0175","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/rheumatology\/kes055","article-title":"Evaluation of a new multi-parallel line immunoassay for systemic sclerosis-associated antibodies in an Asian population","volume":"51","author":"Low","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103536_bb0180","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/rheumatology\/keq446","article-title":"Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach","volume":"50","author":"Van Praet","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103536_bb0185","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1373\/clinchem.2003.023994","article-title":"Parallel detection of autoantibodies with microarrays in rheumatoid diseases","volume":"50","author":"Feng","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2024.103536_bb0190","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/ard.56.11.667","article-title":"Prevalence and clinical relevance of 52-kDa and 60-kDa Ro\/SS-A autoantibodies in Japanese patients with systemic sclerosis","volume":"56","author":"Fujimoto","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103536_bb0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-6-2","article-title":"Prevalence of antibodies to Ro-52 in a serologically defined population of patients with systemic sclerosis","volume":"6","author":"Parker","year":"2009","journal-title":"J Autoimmune Dis"},{"key":"10.1016\/j.autrev.2024.103536_bb0200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/pin.13221","article-title":"Antinuclear antibody pattern and autoantibody profiling of systemic sclerosis patients in a tertiary referral center in North India","volume":"72","author":"Machhua","year":"2022","journal-title":"Pathol Int"},{"key":"10.1016\/j.autrev.2024.103536_bb0205","article-title":"Combining multi-antigenic immunodot with indirect immunofluorescence on HEp-2 cells improves the diagnosis of systemic sclerosis","volume":"229","author":"Bost","year":"2021","journal-title":"Clin Immunol Orlando Fla"},{"key":"10.1016\/j.autrev.2024.103536_bb0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.advms.2020.12.007","article-title":"Metabolic mediators determine the association of antinuclear antibody subtypes with specific clinical symptoms in systemic sclerosis","volume":"66","author":"Stochmal","year":"2021","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.autrev.2024.103536_bb0215","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1111\/ajd.13511","article-title":"Auto-antibody profile and clinical presentation of Vietnamese with systemic sclerosis","volume":"62","author":"Do","year":"2021","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.autrev.2024.103536_bb0220","first-page":"189","article-title":"The prevalence and significance of anti-PM\/Scl antibodies in systemic sclerosis","volume":"28","author":"Wielosz","year":"2021","journal-title":"Ann Agric Environ Med"},{"key":"10.1016\/j.autrev.2024.103536_bb0225","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/03009742.2021.1887927","article-title":"Anti-Ro52\/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients","volume":"50","author":"Lee","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2024.103536_bb0230","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.semarthrit.2019.05.005","article-title":"Evaluation of risk factors for pseudo-obstruction in systemic sclerosis","volume":"49","author":"Dein","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103536_bb0235","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1093\/rheumatology\/keab735","article-title":"Association between autoantibodies in systemic sclerosis and cancer in a national registry","volume":"61","author":"Hoa","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103536_bb0240","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000732","article-title":"Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sj\u00f6gren\u2019s syndrome and systemic sclerosis","volume":"9","author":"Andraos","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2024.103536_bb0245","doi-asserted-by":"crossref","first-page":"1045523","DOI":"10.3389\/fimmu.2022.1045523","article-title":"Comprehensive autoantibody profiles in systemic sclerosis: clinical cluster analysis","volume":"13","author":"H\u00f6ppner","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103536_bb0250","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/08916934.2021.1907842","article-title":"Autoantibody profiles in systemic sclerosis; a comparison of diagnostic tests","volume":"54","author":"Alkema","year":"2021","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2024.103536_bb0255","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejim.2023.07.010","article-title":"Prevalence of anti-synthetase antibodies among systemic sclerosis patients","volume":"117","author":"Garra","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2024.103536_bb0260","doi-asserted-by":"crossref","first-page":"1255540","DOI":"10.3389\/fimmu.2023.1255540","article-title":"Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array","volume":"14","author":"Kuzumi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103536_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117457","article-title":"The diagnostic and prognostic value of a line immunoblot assay in Taiwanese patients with systemic sclerosis","volume":"547","author":"Yen","year":"2023","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"10.1016\/j.autrev.2024.103536_bb0270","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3390\/jcm12020657","article-title":"Autoantibodies and clinical correlations in polish systemic sclerosis patients: a cross-sectional study","volume":"12","author":"\u017bebryk","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2024.103536_bb0275","doi-asserted-by":"crossref","first-page":"rkad036","DOI":"10.1093\/rap\/rkad036","article-title":"Clinical and serological correlation of systemic sclerosis in Moroccan patients","volume":"7","author":"Ouazahrou","year":"2023","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.autrev.2024.103536_bb0280","unstructured":"Ottawa Hospital Research Institute n.d. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp (accessed September 1, 2023)."},{"key":"10.1016\/j.autrev.2024.103536_bb0285","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103536_bb0290","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/art.38219","article-title":"Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: new data from a French cohort and a systematic review and meta-analysis","volume":"66","author":"Sobanski","year":"2014","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.autrev.2024.103536_bb0295","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/sarh.2001.20268","article-title":"Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants","volume":"30","author":"Reveille","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103536_bb0300","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/rheumatology\/ket295","article-title":"Anti-SSA Ro52\/Ro60 antibody testing by immunodot could help the diagnosis of Sjogren\u2019s syndrome in the absence of anti-SSA\/SSB antibodies by ELISA","volume":"52","author":"Mekinian","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103536_bb0305","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-212915","article-title":"Detection of myositis-specific antibodies","volume":"78","author":"Vulsteke","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103536_bb0310","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10067-021-05879-1","article-title":"Myositis autoantibodies in Iranian myositis patients: assessment the frequency and clinical relevancy","volume":"41","author":"Ebrahimi","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103536_bb0315","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","article-title":"Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody","volume":"41","author":"Marie","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103536_bb0320","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.revmed.2015.03.013","article-title":"Antisynthetase syndrome with pulmonary hypertension: 4 original observations","volume":"36","author":"Lecomte","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.autrev.2024.103536_bb0325","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1756-185X.14251","article-title":"Predictive factors for concomitant pulmonary arterial hypertension at diagnosis of systemic lupus erythematosus in a Chinese population","volume":"25","author":"Pan","year":"2022","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103536_bb0330","doi-asserted-by":"crossref","first-page":"9195157","DOI":"10.1155\/2023\/9195157","article-title":"Clinical significance of different profiles of anti-Ro antibodies in connective tissue diseases","volume":"2023","author":"Yang","year":"2023","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2024.103536_bb0335","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1093\/rheumatology\/keac090","article-title":"Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease","volume":"61","author":"Gui","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103536_bb0340","article-title":"Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis","volume":"10","author":"Nayebirad","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.autrev.2024.103536_bb0345","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-023-03141-4","article-title":"Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study","volume":"25","author":"Hamberg","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103536_bb0350","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41584-023-01044-x","article-title":"Systemic sclerosis interstitial lung disease: unmet needs and potential solutions","volume":"20","author":"Liakouli","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2024.103536_bb0355","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.reuma.2015.10.010","article-title":"Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez","volume":"12","author":"Menor Almagro","year":"2016","journal-title":"Spain Reumatol Clin"},{"key":"10.1016\/j.autrev.2024.103536_bb0360","article-title":"Ro52\/TRIM21 - from host defense to autoimmunity","volume":"393\u2013394","author":"Holwek","year":"2023","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2024.103536_bb0365","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1165\/rcmb.2018-0366OC","article-title":"TRIM21 mitigates human lung microvascular endothelial Cells\u2019 inflammatory responses to LPS","volume":"61","author":"Li","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.autrev.2024.103536_bb0370","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00296-017-3718-1","article-title":"A review of the role and clinical utility of anti-Ro52\/TRIM21 in systemic autoimmunity","volume":"37","author":"Lee","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2024.103536_bb0375","first-page":"145","article-title":"Extraordinary antigenicity of the human Ro52 autoantigen","volume":"2","author":"Burbelo","year":"2010","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.autrev.2024.103536_bb0380","article-title":"Combined anti-Ro52\/TRIM21 and anti-Ro60\/SSA antibodies are associated with increased Sj\u00f6gren\u2019s disease severity through interferon pathway activation","author":"Bettacchioli","year":"2023","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.autrev.2024.103536_bb0385","doi-asserted-by":"crossref","first-page":"36478","DOI":"10.1074\/jbc.M111.241786","article-title":"Anti-Ro52 autoantibodies from patients with Sj\u00f6gren\u2019s syndrome inhibit the Ro52 E3 ligase activity by blocking the E3\/E2 interface","volume":"286","author":"Espinosa","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2024.103536_bb0390","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/annrheumdis-2014-206297","article-title":"Interaction between innate immunity and Ro52-induced antibody causes Sj\u00f6gren\u2019s syndrome-like disorder in mice","volume":"75","author":"Szczerba","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103536_bb0395","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.3390\/ijms19102935","article-title":"Immune response targeting Sj\u00f6gren\u2019s syndrome antigen Ro52 suppresses tear production in female mice","volume":"19","author":"Trzeciak","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2024.103536_bb0400","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.20041859","article-title":"Ro\/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block","volume":"201","author":"Salomonsson","year":"2005","journal-title":"J Exp Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224000272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224000272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T18:26:11Z","timestamp":1716229571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224000272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1568997224000272"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103536","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of anti-Ro52-kDa\/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103536"}}